Hong Kong Stock Announces Nuggets | BYD's automobile sales in September were about 463,600 vehicles, up 16.98% year-on-year

Important matters:

Quanxin Bio-B (02509): Results of the phase III clinical study of ortotibalizumab (QX005N) for prurigo nodular were released in EADV 2026 in the form of a groundbreaking oral report

Controlling ownership changed, KFM Jinde (03816) obtained Lixun Precision (02475) to acquire 57.0% of the shares and withdraw cash to resume trading on October 2

A subsidiary of Hailuo Cement (00914) acquired shares in a number of companies for a total of 307 million yuan to lay out the medical waste business market in Northeast China and the Bohai Rim region

FORTIOR (01304) subsidiary plans to acquire all shares of Sciosense B.V., for $95.7833 million

China Technology Group (01725) subsidiary plans to sell all of Steady Elite Limited's shares for HK$3.696 million

Insili Intelligence (03696) nominates a new generation of small molecule GIPR antagonists, potentially used to intervene in obesity and related diseases

Operating performance:

BYD shares (01211) sold about 463,600 vehicles in September, up 16.98% year-on-year

The total sales volume of Geely Auto (00175) in September was 292,168 units, up about 7% year on year

Rantu Auto (07489) delivered 115,481 new cars in the first nine months, a 19% year-on-year increase

Great Wall Motor (02333)'s total car sales volume in September was about 114,900 units, down 13.99% year on year

Ideal Automobile-W (02015) delivers 31,817 new cars in September

VALA (02051): A total of 420 VALA vehicles were delivered to subscribers in the third quarter